Display options
Share it on

Comput Struct Biotechnol J. 2021 Dec 16;20:230-240. doi: 10.1016/j.csbj.2021.12.021. eCollection 2022.

Dynorphin A induces membrane permeabilization by formation of proteolipidic pores. Insights from electrophysiology and computational simulations.

Computational and structural biotechnology journal

D Aurora Perini, Marcel Aguilella-Arzo, Antonio Alcaraz, Alex Perálvarez-Marín, María Queralt-Martín

Affiliations

  1. Laboratory of Molecular Biophysics. Department of Physics. Universitat Jaume I, 12071 Castellón, Spain.
  2. Biophysics Unit, Department of Biochemistry and Molecular Biology, School of Medicine, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.
  3. Institute of Neuroscience, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.

PMID: 35024095 PMCID: PMC8718563 DOI: 10.1016/j.csbj.2021.12.021

Abstract

Dynorphins are endogenous neuropeptides that function as ligands for the κ-opioid receptor. In addition to opioid activity, dynorphins can induce several pathological effects such as neurological dysfunctions and cell death. Previous studies have suggested that Dynorphin A (DynA) mediates some pathogenic actions through formation of transient pores in lipid domains of the plasma membrane. Here, we use planar bilayer electrophysiology to show that DynA induces pore formation in negatively charged membranes. We find a large variability in pore conformations showing equilibrium conductance fluctuations, what disregards electroporation as the dominant mechanism of pore formation. Ion selectivity measurements showing cationic selectivity indicate that positive protein charges of DynA are stabilized by phosphatidyl serine negative charges in the formation of combined structures. We complement our study with computational simulations that assess the stability of diverse peptide arrangements in the hydrophobic core of the bilayer. We show that DynA is capable of assembling in charged membranes to form water-filled pores that conduct ions.

© 2021 The Authors.

Keywords: Computational simulations; Dynorphin; Ion channel; Membrane permeabilization; Noise and fluctuations; Protein-lipid interactions; Proteolipidic pores

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. Front Biosci. 2005 Jan 01;10:216-35 - PubMed
  2. Biophys J. 2016 Sep 20;111(6):1248-1257 - PubMed
  3. Biochim Biophys Acta. 2016 Jan;1858(1):30-7 - PubMed
  4. Front Biosci. 2003 May 01;8:d1055-71 - PubMed
  5. Int J Pept Protein Res. 1991 Dec;38(6):505-10 - PubMed
  6. Hum Mol Genet. 2016 Jul 1;25(13):2728-2737 - PubMed
  7. J Phys Chem B. 2021 Jun 10;125(22):5676-5682 - PubMed
  8. Biophys J. 2002 Apr;82(4):1985-94 - PubMed
  9. Phys Rev Lett. 2009 Jun 26;102(25):256804 - PubMed
  10. Proc Natl Acad Sci U S A. 1972 Dec;69(12):3561-6 - PubMed
  11. Biophys J. 2021 Oct 19;120(20):4557-4574 - PubMed
  12. Biophys J. 1993 Dec;65(6):2455-60 - PubMed
  13. Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11852-7 - PubMed
  14. Exp Cell Res. 2001 Sep 10;269(1):54-63 - PubMed
  15. J Biol Chem. 2005 Jul 15;280(28):26360-70 - PubMed
  16. Sci Rep. 2018 Dec 20;8(1):18000 - PubMed
  17. FASEB J. 2006 Oct;20(12):2124-6 - PubMed
  18. J Mol Graph. 1996 Feb;14(1):33-8, 27-8 - PubMed
  19. Nano Lett. 2018 Oct 10;18(10):6604-6610 - PubMed
  20. Chem Rev. 2019 May 8;119(9):6227-6269 - PubMed
  21. Brain Res. 1990 Jan 15;507(1):1-5 - PubMed
  22. Biochemistry. 1995 Sep 12;34(36):11479-88 - PubMed
  23. Bioelectrochemistry. 2021 Feb;137:107641 - PubMed
  24. ACS Nano. 2017 Oct 24;11(10):10392-10400 - PubMed
  25. Int J Mol Sci. 2019 Aug 30;20(17): - PubMed
  26. FEBS Lett. 2006 May 29;580(13):3201-5 - PubMed
  27. Nat Rev Microbiol. 2012 Jul 02;10(8):563-74 - PubMed
  28. Chem Biodivers. 2007 Jun;4(6):1323-37 - PubMed
  29. J Chem Theory Comput. 2016 Jan 12;12(1):405-13 - PubMed
  30. J Med Chem. 2003 May 22;46(11):2104-9 - PubMed
  31. Biophys J. 2013 Jan 8;104(1):146-55 - PubMed
  32. Phys Rev Lett. 2006 Jan 27;96(3):038101 - PubMed
  33. PLoS Comput Biol. 2010 Jun 10;6(6):e1000810 - PubMed
  34. Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18453-8 - PubMed
  35. Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7447-7454 - PubMed
  36. J Neurosci. 1995 Jun;15(6):4602-11 - PubMed
  37. Trends Biochem Sci. 2014 Nov;39(11):510-6 - PubMed
  38. Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14243-8 - PubMed
  39. Biochim Biophys Acta Biomembr. 2018 May;1860(5):1015-1021 - PubMed
  40. J Phys Chem B. 2021 Feb 4;125(4):981-994 - PubMed
  41. Cell Death Dis. 2015 Mar 12;6:e1683 - PubMed
  42. FEBS Lett. 1992 Sep 21;310(1):13-6 - PubMed
  43. Phys Chem Chem Phys. 2014 Mar 7;16(9):3881-93 - PubMed
  44. J Neurosci. 2009 Nov 11;29(45):14371-80 - PubMed
  45. Biophys J. 2021 Jun 1;120(11):2330-2342 - PubMed
  46. Proteins. 2008 Mar;70(4):1488-97 - PubMed
  47. Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17742-7 - PubMed
  48. Phys Rev Lett. 2002 Oct 7;89(15):158101 - PubMed
  49. Nat Rev Drug Discov. 2011 Dec 16;11(1):37-51 - PubMed
  50. J Chem Inf Model. 2020 Oct 26;60(10):5142-5152 - PubMed
  51. Nat Struct Biol. 1996 Oct;3(10):842-8 - PubMed
  52. Chem Phys Lipids. 2010 Jun;163(6):630-7 - PubMed
  53. Eur Biophys J. 2001 Aug;30(4):233-41 - PubMed
  54. Biochim Biophys Acta. 1991 Feb 11;1062(1):94-102 - PubMed
  55. Science. 1982 Dec 10;218(4577):1136-8 - PubMed
  56. Neurobiol Aging. 2007 Nov;28(11):1700-8 - PubMed
  57. Eur Biophys J. 2002 Oct;31(6):454-66 - PubMed
  58. Biochemistry. 2013 Jun 18;52(24):4157-67 - PubMed
  59. Structure. 2016 Dec 6;24(12):2207-2216 - PubMed
  60. Biophys J. 2015 May 19;108(10):2424-2426 - PubMed
  61. Phys Rev Lett. 2000 Jul 3;85(1):202-5 - PubMed
  62. PLoS Comput Biol. 2010 Feb 05;6(2):e1000663 - PubMed
  63. Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):786-91 - PubMed
  64. J Physiol. 1949 Mar 1;108(1):37-77 - PubMed
  65. Nano Lett. 2016 Apr 13;16(4):2205-12 - PubMed
  66. Biochim Biophys Acta. 2008 May;1778(5):1267-73 - PubMed
  67. Biochem Biophys Res Commun. 2011 Jul 22;411(1):111-4 - PubMed
  68. Front Pharmacol. 2020 May 20;11:697 - PubMed
  69. Phys Rev Lett. 2009 Oct 30;103(18):180601 - PubMed
  70. FEBS Lett. 2012 Jul 30;586(16):2529-34 - PubMed
  71. Biochim Biophys Acta. 2008 Nov;1778(11):2580-7 - PubMed
  72. Virology. 2012 Oct 25;432(2):485-94 - PubMed
  73. Nat Methods. 2017 Jan;14(1):71-73 - PubMed
  74. Biochemistry. 2006 Dec 26;45(51):15931-40 - PubMed
  75. Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6382-7 - PubMed
  76. Front Mol Biosci. 2020 Sep 23;7:565797 - PubMed
  77. Synapse. 1993 Apr;13(4):357-69 - PubMed
  78. Biomed Pharmacother. 2018 Dec;108:1090-1096 - PubMed
  79. Biophys J. 2009 Jan;96(1):56-66 - PubMed

Publication Types